Veru Inc. (VERU)
Veru Inc. (VERU) is a pharmaceutical company that develops and commercializes specialized medicines primarily for the treatment of men's health, including prostate cancer, benign prostatic hyperplasia, and sexual health. The company also focuses on infectious disease products, including treatments for COVID-19, and has a portfolio that includes both FDA-approved drugs and pipeline candidates. Founded in 1998, Veru aims to address unmet medical needs with innovative therapies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 7, 2014 | $0.07 | 2014-04-28 | 2014-04-30 |
| February 5, 2014 | $0.07 | 2014-01-27 | 2014-01-29 |
| November 6, 2013 | $0.07 | 2013-10-28 | 2013-10-30 |
| August 7, 2013 | $0.07 | 2013-07-29 | 2013-07-31 |
| May 8, 2013 | $0.07 | 2013-04-29 | 2013-05-01 |
Dividends Summary
- Veru Inc. has issued 18 dividend payments over the past 4 years
- The most recent dividend was paid 4154 days ago, on May 7, 2014
- The highest dividend payed out to investors during this period was $0.07 per share
- The average dividend paid during this period was $0.06 per share.
Company News
Veru sells its FC2 Female Condom business for $18 million, reducing its workforce by 90% and refocusing on its biopharma pipeline, including late-stage trials for enobosarm to treat weight loss in GLP-1-treated patients.
Veru Inc. has sold its FC2 Female Condom business for $18 million, allowing the company to focus on its late-stage biopharmaceutical pipeline, including a Phase 2b clinical trial evaluating enobosarm to preserve muscle and augment fat loss in patients receiving the GLP-1 receptor agonist Wegovy.
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Can these top tips help your penny stocks trading? The post Advanced Penny Stocks Research Methods appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.